India & Oman pharmaceutical industry market is estimated to be valued at US$ 47,179.5 million in 2021 and is expected to exhibit a CAGR of 12.7% over the forecast period (2021-2030) | Pfizer, Inc., Bristol Myers Squibb, Sanofi S.A., F. Hoffmann-La Roche AG

Market Overview:

The pharmaceutical industry consists of sales of pharmaceuticals product & services by organization and sole trader that develop pharmaceuticals utilized in treating diseases such as cancer, diabetes, cardiovascular disease, chronic kidney diseases, autoimmune disorder, and others.

Competitive Landscape:

Pfizer, Inc., Bristol Myers Squibb, Sanofi S.A., F. Hoffmann-La Roche AG, Bayer AG, Novartis International AG, Merck & Co., Inc., AbbVie, GlaxoSmithKline plc, Eli Lilly and Company, Zydus Cadila, Aurobindo Pharma Ltd., Cipla Ltd., Dr. Reddy’s Laboratories Ltd., Lupin Ltd., Sun Pharmaceutical Industries Limited, Serum Institute of India Pvt. Ltd., Biocon Limited, Strides Pharma Science Limited, and Unichem Laboratories

𝐂𝐡𝐫𝐢𝐬𝐭𝐦𝐚𝐬 𝐒𝐚𝐥𝐞 𝐈𝐬 𝐋𝐢𝐯𝐞!

𝐁𝐮𝐲 𝐍𝐨𝐰 𝐓𝐨 𝐀𝐯𝐚𝐢𝐥 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐅𝐫𝐨𝐦 𝟐𝟓-𝟑𝟎% 𝐭𝐢𝐥𝐥 𝟑𝟏-𝐃𝐞𝐜-𝟐𝟎𝟐𝟏

Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/4569

Key Drivers

Increasing launch of new product in India is expected to drive India pharmaceutical industry market. For instance, in February 2021, Glenmark Pharmaceuticals, a pharmaceutical company in India, announced the launch of SUTIB, a generic version of Sunitinib oral capsules indicated for the treatment of kidney cancer in India.

Growing prevalence of chronic diseases is also expected to augment growth of the market. According to a report by WHO (World Health Organization), chronic diseases like cardiovascular disorders, asthma, mental health disorders, etc., are the leading causes of death and disability in India. The report also suggests a significant increase in chronic illnesses in India over the next 25 years.

Covid-19 Impact Analysis 

The major challenges faced by key players during Covid-19 pandemic are supply of raw materials needed for production of instruments and reagent kits owing to disruption in transportation facility, irregular demand for products from the retailers owing to growing number of patients suffering from COVID-19 and other life threatening disorders. Thus, to overcome the dependency of active pharmaceutical ingredient (API) and raw materials, the Indian government is focused on developing and manufacturing of raw materials and active pharmaceutical ingredients. For instance, in 2020, the government of India announced the incentive package of INR 13.76 billion (US$ 18.39 Bn) for the promotion of domestic manufacturing of critical key starting materials, drug intermediates, APIs, and medical devices in India. Moreover, according to the Directorate-General of Pharmacy and Drug Control Oman 2020, in Oman there was restriction on the export of masks, hand sanitizers, and medical supply products to the other countries due to shortage of the medical products in Oman.

Key Takeaways:

1. The India & Oman pharmaceutical industry market is expected to exhibit a CAGR of 12.7% over the forecast period owing to the growing prevalence of chronic disease and increasing government initiatives in the pharmaceutical industry

Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/4569

Table of Contents

1. Research Objectives and Assumptions
   • Research Objectives
   • Assumptions
   • Abbreviations
2. Market Purview
   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snapshot, By Drug
     • Market Snapshot, By Type
     • Market Snapshot, By Drug Class
     • Market Snapshot, By Application
     • Market Snapshot, By Distribution Channel
     • Market Snapshot, By Country
     • Market Opportunity Map
3. India & Oman Pharmaceutical Industry Market
   • Analysis of the Indian Pharmaceutical Industry
     • Drivers & Restraints
     • Market Opportunity
     • Market Trends
     • Impact Analysis
     • Mergers and Acquisitions
     • Epidemiology
     • PEST Analysis
     • SWOT Analysis
     • Regulatory Scenario
     • Reimbursement Scenario
     • Major Indian Exporters/Manufacturers (Global)
     • Major Indian Importers
     • Major Indian Exporters/Manufacturers (To Oman)
     • Indian Pharmaceutical Drugs Import Market
     • Indian Pharmaceutical Drugs Export Market
       • Indian Pharmaceutical Drugs Export to Oman Market
   • Analysis of the Oman Pharmaceutical Industry
     • Drivers & Restraints
     • Market Opportunity
     • Market Trends
     • Impact Analysis
     • Mergers and Acquisitions
     • Epidemiology
     • PEST Analysis
     • SWOT Analysis
     • Regulatory Scenario
     • Industry Regulations
       • Trade Regulations and Procedures For Export to Oman
       • Trade Barriers (Tariff, Non-tariff, etc.) and Other Entry-level Barriers for Indian Pharma Products in Oman
     • Reimbursement Scenario
     • Major Oman Exporters/Manufacturers (Global)
     • Major Oman Importers
     • Strategy For Indian Pharma Products In Oman
     • India’s Strategy For Effectively Entering Oman Pharma Market
     • USP Of Indian Companies In The Oman Pharmaceutical Market And Positioning Strategy
     • Oman Pharmaceutical Drugs Import Market
     • Oman Pharmaceutical Drugs Export Market
       • Oman Pharmaceutical Drugs Export to India Market
     • Ayurvedic Drugs Market
       • Overview of Indian Ayurvedic Drugs
       • Ayurvedic Products by Indian Companies With Certification of Pharmaceutical Product (COPP) Granted As Per WHO-GMP Certification Scheme (1/2)
       • Overview of Oman Ayurvedic Drugs Import
       • Indian Ayurvedic Companies Registered in Oman
     • Strategies Adopted By Local Oman Manufacturers
4. India & Oman Pharmaceutical Industry Market – Impact of Coronavirus (Covid-19) Pandemic
   
   • Economic Impact
   • Impact of COVID-19 on Pharmaceutical Market
   • Demand and Supply Chain Analysis
   • Government Initiative
5. India & Oman Pharmaceutical Industry Market, By Drug, 2011 – 2030 (US$ Million)
   • Introduction
     • Market Share Analysis, 2021 and 2030 (%)
     • Y-o-Y Growth Analysis, 2012 – 2030
     • Segment Trends
   • Generic
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
   • Patented (Branded)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
6. India & Oman Pharmaceutical Industry Market, By Type, 2011 – 2030 (US$ Million)
   • Introduction
     • Market Share Analysis, 2021 and 2030 (%)
     • Y-o-Y Growth Analysis, 2012 – 2030
     • Segment Trends
   • Prescription Drugs
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
   • Over the Counter Drugs
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million
7. India & Oman Pharmaceutical Industry Market, By Drug Class, 2011 – 2030 (US$ Million)
   • Introduction
     • Market Share Analysis, 2021 and 2030 (%)
     • Y-o-Y Growth Analysis, 2012 – 2030
     • Segment Trends
   • Analgesics
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
   • Anesthetics
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
   • Antibacterials
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
   • Antidepressants
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
   • Corticosteroids
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
   • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
   • Anticonvulsants
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
   • Antivirals
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
   • Anticoagulants
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
   • ACE inhibitors
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
   • Hormonal agents
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
   • Insulin
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
   • Contraceptives
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
   • Diuretics
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
   • Vaccines
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
   • Others
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
8. India & Oman Pharmaceutical Industry Market, By Application, 2011 – 2030 (US$ Million)
   • Introduction
     • Market Share Analysis, 2021 and 2030 (%)
     • Y-o-Y Growth Analysis, 2012 – 2030
     • Segment Trends
   • Cardiovascular
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
     • Ischemic Heart Disease
     • Others
   • Hypertension
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
   • Musculoskeletal
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
   • Oncology
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
   • Anti-infective
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
   • Metabolic Disorder
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
     • Diabetes
     • Others
   • Weight Management
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
   • Central Nervous System
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
   • Genito-urinary
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
   • Kidney Disease
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
   • Gastrointestinal
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
   • Respiratory
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
   • Hematology
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
   • Dermatology
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
   • Ophthalmology
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
   • Others (Nutraceutical, Dentals, and Gynecology)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
9. India & Oman Pharmaceutical Industry Market, By Distribution Channel, 2011 – 2030 (US$ Million)
   • Introduction
     • Market Share Analysis, 2021 and 2030 (%)
     • Y-o-Y Growth Analysis, 2012 – 2030
     • Segment Trends
   • Hospital Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
   • Online Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
   • Retail Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
10. India & Oman Pharmaceutical Industry Market, By Country, 2011 – 2030 (US$ Million)
    • Introduction
      • Market Share Analysis, 2021 and 2030 (%)
      • Y-o-Y Growth Analysis, 2012 – 2030
      • Regional Trends
    • India
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug, 2011 – 2030 (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2011 – 2030 (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2011 – 2030 (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2011 – 2030 (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2011 – 2030 (US$ Million)
    • Oman
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug, 2011 – 2030 (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2011 – 2030 (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2011 – 2030 (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2011 – 2030 (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2011 – 2030 (US$ Million)

Get FREE Sample Report with Latest Covid19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/4569

About Us:

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837